Competitors in the diabetes market are working to meet consumer demand for more digitally integrated and interconnected diabetes management solutions, and collaborations among the various participants represent the new norm in this industry. In this ICYMI, Big pharma Eli Lilly partners with medtech to shift its diabetes focus from molecules to outcomes.
Apple recently made a splash with its new ECG-enabled watch, but technology from an Israeli start-up may have a better chance of penetrating the multibillion-dollar ambulatory cardiac arrhythmia monitoring market. An excerpt from Executive Editor Mary Thompson’s October 31 feature, “Ambulatory ECG Monitoring Enters a New, More Patient-Friendly Era.”
Sloan Gaon, CEO of PulsePoint, a programmatic health technology company that uses data and technology to engage consumers and personalize healthcare advertising on the web, talks with the Community Blog about how the new Apple Watch and other tech and data initiatives are driving the shift to “radical health personalization.”
Neuro-focused prescription digital health companies are taking aim at a range of diseases from psychiatric and mental health disorders to neurodegenerative diseases. In this excerpt from our September 28 feature, “Digital Taps Into Neurological Function,” Mark Ratner talks with William Marks, MD, about Verily Life Sciences’ activities in the field.
In Part 2 of our interview, Rick Valencia, President of Qualcomm Life, tells us about his company’s recent partnership with AlertWatch Inc. to provide real-time intelligence to anesthesiologists in the operating room (and those monitoring patients remotely). He also talks about what’s next in the evolution toward value-based care, and his personal passion for the medtech industry.
The Community Blog caught up with Rick Valencia, President of Qualcomm Life, three years after his Q&A interview with MedTech Strategist’s co-editor-in-chief, David Cassak, to find out where we stand with the value-based healthcare evolution, and Qualcomm Life’s initiatives in this important area. In Part 1 of our interview, Valencia talks about the current status of mobile health and wireless connectivity in the device space, what still needs to happen, and how his company is helping to propel this movement forward.
Virtual reality and other tech-enabled digital tools are entering the healthcare education arena with a promise to make clinician training and assessment more flexible, efficient, and user-friendly. One of the most active pioneers in this space is medtech giant Johnson & Johnson. J&J’s professional education unit, the Johnson & Johnson Institute, is embracing a variety of digital learning tools, ranging from virtual and augmented reality to AI-driven online learning tools. And its efforts could have far-reaching implications for both J&J and the clinicians it serves.
Robert Califf is on a mission to improve the clinical trial process behind medical products through the use of big data. The ex-FDA head and other prominent physician-scientists explain how clinical grade-big data initiatives are delving deep into human health, as part of disruptive initiatives that will affect us all.
In this week’s post, we continue our look at executives working to make an impact in surgical robotics, including David McNally, CEO of Titan Medical, and Christopher Prentice, CCO at Mazor Robotics. Also, we note a few observations from last week’s annual Society of Robotic Surgery (SRS) conference in Stockholm, where key executives from all the major robotics companies assembled to discuss the current status and future of the field. [Read Part 1]
Back in 1990, the same year that Americans were paying on average $1.34 for a gallon of gas, Space Shuttle Discovery placed the Hubble Space Telescope into orbit, and Tim Berners-Lee of Switzerland published his formal proposal for a concept called the “World Wide Web,” the surgical robotics revolution was born. [Read Part 2]